Cargando…
Effectiveness of Insulin Degludec in Thai Patients with Diabetes Mellitus: Real-World Evidence From a Specialized Diabetes Center
Background Insulin degludec, an ultra-long-acting insulin analogue, has been available in Thailand since October 2016. Although clinical trial results revealed less hypoglycemia, data from real-world settings is limited especially in Asian patients. This study aimed to evaluate prospectively the rea...
Autores principales: | Thewjitcharoen, Yotsapon, Yenseung, Nalin, Malidaeng, Areeya, Butadej, Siriwan, Chotwanvirat, Phawinpon, Krittiyawong, Sirinate, Thammawiwat, Chattip, Himathongkam, Thep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416321/ https://www.ncbi.nlm.nih.gov/pubmed/31597169 http://dx.doi.org/10.1055/a-0899-5118 |
Ejemplares similares
-
Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2017) -
Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010–2018: Experience from a tertiary diabetes center in Bangkok
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2020) -
Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2023) -
Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2019) -
Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2018)